Vanguard Group Inc Dyne Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,760,414 shares of DYN stock, worth $184 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,760,414
Previous 7,651,157 27.57%
Holding current value
$184 Million
Previous $72.8 Million 69.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$8.18 - $14.22 $17.3 Million - $30 Million
2,109,257 Added 27.57%
9,760,414 $123 Million
Q2 2025

Aug 11, 2025
BUY
$6.81 - $14.78 $1.67 Million - $3.62 Million
244,813 Added 3.31%
7,651,157 $72.8 Million
Q1 2025

May 09, 2025
BUY
$10.46 - $25.46 $7.35 Million - $17.9 Million
702,418 Added 10.48%
7,406,344 $77.5 Million
Q4 2024

Feb 11, 2025
SELL
$23.56 - $35.55 $3.77 Million - $5.7 Million
-160,211 Reduced 2.33%
6,703,926 $158 Million
Q3 2024

Nov 13, 2024
BUY
$31.94 - $47.04 $68.5 Million - $101 Million
2,146,083 Added 45.49%
6,864,137 $247 Million
Q2 2024

Aug 13, 2024
BUY
$23.65 - $35.63 $30.2 Million - $45.5 Million
1,277,784 Added 37.14%
4,718,054 $167 Million
Q1 2024

May 10, 2024
BUY
$13.06 - $29.18 $14.5 Million - $32.4 Million
1,110,629 Added 47.67%
3,440,270 $97.7 Million
Q4 2023

Feb 14, 2024
SELL
$6.62 - $13.64 $229,535 - $472,939
-34,673 Reduced 1.47%
2,329,641 $31 Million
Q3 2023

Nov 14, 2023
SELL
$8.6 - $12.18 $210,072 - $297,520
-24,427 Reduced 1.02%
2,364,314 $21.2 Million
Q2 2023

Aug 14, 2023
BUY
$8.53 - $14.28 $8.04 Million - $13.5 Million
941,984 Added 65.11%
2,388,741 $26.9 Million
Q1 2023

May 15, 2023
SELL
$10.88 - $15.0 $2.15 Million - $2.96 Million
-197,653 Reduced 12.02%
1,446,757 $16.7 Million
Q4 2022

Feb 10, 2023
BUY
$9.37 - $13.8 $2.87 Million - $4.22 Million
306,045 Added 22.87%
1,644,410 $19.1 Million
Q3 2022

Nov 14, 2022
BUY
$7.2 - $15.17 $123,408 - $260,013
17,140 Added 1.3%
1,338,365 $17 Million
Q2 2022

Aug 12, 2022
SELL
$4.36 - $10.5 $317,041 - $763,518
-72,716 Reduced 5.22%
1,321,225 $9.08 Million
Q1 2022

May 13, 2022
BUY
$6.52 - $12.27 $7,947 - $14,957
1,219 Added 0.09%
1,393,941 $13.4 Million
Q4 2021

Feb 14, 2022
BUY
$11.89 - $16.07 $1.18 Million - $1.6 Million
99,380 Added 7.68%
1,392,722 $16.6 Million
Q3 2021

Nov 12, 2021
BUY
$15.6 - $21.46 $1.22 Million - $1.68 Million
78,459 Added 6.46%
1,293,342 $21 Million
Q2 2021

Aug 13, 2021
BUY
$15.94 - $22.33 $19.4 Million - $27.1 Million
1,214,883 New
1,214,883 $25.6 Million

Others Institutions Holding DYN

# of Institutions
227
Shares Held
148M
Call Options Held
184K
Put Options Held
243K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $975M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email